NYSE:APHA - Aphria Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$10.18 -0.20 (-1.93 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$10.18
Today's Range$9.82 - $10.59
52-Week Range$3.75 - $16.86
Volume8.43 million shs
Average Volume10.23 million shs
Market Capitalization$2.55 billion
P/E Ratio115.33
Dividend YieldN/A
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual Sales$29.05 million



Market Cap$2.55 billion
Next Earnings Date4/15/2019 (Estimated)
OptionableNot Optionable

Aphria (NYSE:APHA) Frequently Asked Questions

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) issued its quarterly earnings data on Friday, January, 11th. The company reported ($0.01) earnings per share for the quarter. The business earned $16.58 million during the quarter. View Aphria's Earnings History.

When is Aphria's next earnings date?

Aphria is scheduled to release their next quarterly earnings announcement on Monday, April 15th 2019. View Earnings Estimates for Aphria.

What price target have analysts set for APHA?

5 equities research analysts have issued 1-year target prices for Aphria's stock. Their forecasts range from $7.00 to $18.00. On average, they expect Aphria's share price to reach $13.3333 in the next year. This suggests a possible upside of 31.0% from the stock's current price. View Analyst Price Targets for Aphria.

What is the consensus analysts' recommendation for Aphria?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.

Has Aphria been receiving favorable news coverage?

Media stories about APHA stock have been trending somewhat positive on Saturday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aphria earned a news impact score of 1.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Tilray (TLRY), Hexo (HYYDF), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU) and Advanced Micro Devices (AMD).

Who are Aphria's key executives?

Aphria's management team includes the folowing people:
  • Mr. Victor Neufeld, CEO & Director (Age 65)
  • Mr. Cole Cacciavillani, Co-Founder, VP of Growing Operations & Director (Age 64)
  • Mr. John Cervini, Co-Founder, VP of Infrastructure & Technology and Director (Age 48)
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing

Who are Aphria's major shareholders?

Aphria's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (0.98%), TD Asset Management Inc. (0.28%), Bank of America Corp DE (0.15%), Toronto Dominion Bank (0.05%), CIBC Asset Management Inc (0.05%) and Commonwealth Equity Services LLC (0.03%).

Which major investors are buying Aphria stock?

APHA stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, TD Asset Management Inc., Bank of America Corp DE, Toronto Dominion Bank, CIBC Asset Management Inc, Commonwealth Equity Services LLC, Connor Clark & Lunn Investment Management Ltd. and Jane Street Group LLC.

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $10.18.

How big of a company is Aphria?

Aphria has a market capitalization of $2.55 billion and generates $29.05 million in revenue each year.

MarketBeat Community Rating for Aphria (NYSE APHA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel